Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.

[1]  S. Nightingale.  Two New Therapies Available Under Treatment IND , 1992 .

[2]  M. Cohen,et al.  ACE inhibitor fetopathy and hypocalvaria: The kidney–skull connection , 1991 .

[3]  M. Keirse,et al.  Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. , 1991, Obstetrics and gynecology.

[4]  R. Brent,et al.  Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors. , 1991, Teratology.

[5]  R. Ahokas,et al.  Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensive, term-pregnant rat. , 1990, American journal of obstetrics and gynecology.

[6]  R. Robertson,et al.  Maternotoxicity and Fetotoxicity of an Angiotensin-Converting Enzyme Inhibitor, Enalapril, in Rabbits , 1990 .

[7]  K. Benirschke,et al.  Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. , 1990, American journal of obstetrics and gynecology.

[8]  J. Milstien,et al.  Neonatal Anuria With Maternal Angiotensin- Converting Enzyme Inhibition , 1989, Obstetrics and gynecology.

[9]  N. Modi,et al.  ACE INHIBITORS IN PREGNANCY , 1989, The Lancet.

[10]  D. Purohit,et al.  Neonatal renal failure: a complication of maternal antihypertensive therapy. , 1989, American journal of obstetrics and gynecology.

[11]  K. Huttunen,et al.  Enalapril treatment of a nursing with slightly impaired renal function. , 1989, Clinical nephrology.

[12]  P. Knott,et al.  CONGENITAL RENAL DYSGENESIS POSSIBLY DUE TO CAPTOPRIL , 1989, The Lancet.

[13]  T. Hennigan,et al.  Erythropoietin and autologous blood donation. Reply , 1989 .

[14]  J. Opitz,et al.  Renal tubular dysgenesis: delayed onset of oligohydramnios. , 1989, American journal of medical genetics.

[15]  M. Lindheimer,et al.  Enalapril and pregnancy-induced hypertension. , 1988, Annals of internal medicine.

[16]  P. Plouin,et al.  Angiotensin‐converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril , 1988, British journal of obstetrics and gynaecology.

[17]  G. Schubiger,et al.  Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate. , 1988, Annals of internal medicine.

[18]  S. Kaler,et al.  Hypertrichosis and congenital anomalies associated with maternal use of minoxidil. , 1987, Pediatrics.

[19]  B. Hurault de Ligny,et al.  Captopril therapy in preeclampsia. , 1987, Nephron.

[20]  F. Pipkin,et al.  The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus , 1986, British journal of pharmacology.

[21]  N. Vale,et al.  Effect of captopril on bradykinin inactivation by human foetal placental circulation. , 1986 .

[22]  S. Motoyama,et al.  Treatment of hypertension in pregnancy by a combined drug regimen including captopril , 1986 .

[23]  P. Plouin,et al.  [Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases]. , 1985, Presse medicale.

[24]  N. Gleicher,et al.  Obstetric Ultrasound in the Management of Pregnancy Complicated by Maternal and Fetal Disease , 1985 .

[25]  N. Gleicher.  Principles of Medical Therapy in Pregnancy , 1985, Springer US.

[26]  J. Staessen,et al.  CAPTOPRIL DURING PREGNANCY , 1984, The Lancet.

[27]  P. Vert,et al.  CAPTOPRIL ADMINISTRATION IN PREGNANCY IMPAIRS FETAL ANGIOTENSIN CONVERTING ENZYME ACTIVITY AND NEONATAL ADAPTATION , 1984, The Lancet.

[28]  K. Olsson,et al.  Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus. , 1984, Acta physiologica Scandinavica.

[29]  R. Lorenz,et al.  Can captopril cause fetal and neonatal renal failure? , 1984, Pediatric pharmacology.

[30]  A. Cp.  The Medical Council and medical education. , 1983 .

[31]  P. Wilson,et al.  Management of severe hypertension in pregnancy by a combined drug regimen including captopril: case report. , 1983, The New Zealand medical journal.

[32]  E. K. Weir,et al.  Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. , 1983, The Journal of clinical investigation.

[33]  E. K. Weir,et al.  Captopril: Association with Fetal Death and Pulmonary Vascular Changes in the Rabbit , 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  E. M. Symonds,et al.  The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. , 1982, The Journal of physiology.

[35]  Burge Pd,et al.  Fetal abnormality associated with the use of captopril during pregnancy. , 1981 .

[36]  R. Worley,et al.  Control of vascular responsiveness during human pregnancy. , 1980, Kidney international.

[37]  F. Pipkin,et al.  POSSIBLE RISK WITH CAPTOPRIL IN PREGNANCY: SOME ANIMAL DATA , 1980, The Lancet.

[38]  O. Browne,et al.  PLASMAPHERESIS AND IMMUNOSTIMULATION , 1976, The Lancet.

[39]  K. Catt,et al.  Plasma renin activity during ovine pregnancy. , 1975, The American journal of physiology.

[40]  R. Richart.  Letter: Identity of cervical dysplasias. , 1975, Lancet.

[41]  P. Kittredge.  Assessment of equipment. , 1971, Lancet.

[42]  Clark Dh,et al.  Erythema multiforme and ACTH. , 1953 .